ClinicalTrials.Veeva

Menu

Fatty Liver Disease in Nordic Countries (FLINC)

C

Copenhagen University Hospital, Hvidovre

Status

Enrolling

Conditions

Non-Alcoholic Fatty Liver Disease

Treatments

Diagnostic Test: Proteomics
Genetic: Genomics
Diagnostic Test: Transcriptomics

Study type

Observational

Funder types

Other

Identifiers

NCT04340817
Flinc07042020

Details and patient eligibility

About

A prospective cohort study, which aims to systematically evaluate biomarkers and potential targets in NAFLD and NASH.

Enrollment

634 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Non-alcoholic fatty liver disease and
  • Healthy volunteers

Exclusion criteria

  • Other liver diseases than non-alcoholic fatty liver disease
  • Lack of informed consent

Trial contacts and locations

1

Loading...

Central trial contact

Mikkel P Werge, MD; Lise L Gluud, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems